Onchocerca cervicalis

Onchocerca volvulus -
Strongyloides stercoralis
Chemical structure of ivermectin. Ivermectin is consisted of more than of -O-demethyl-, -dihydroavermectin A a and less than of -O-demethyl--de -methylpropyl -, -dihydro---methylethyl avermectin A a .
Fig. 2 Effects of levamisole and ivermectin on the motility of C. elegans. Suspensions of C. elegans
adults per mL were exposed to drugs at the designated concentrations. After min, the number of motile worms was counted. N , wild-type; E , levamisole-resistant mutant. Modified figure from ref. 
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